Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

Gesamtdokumentation anzeigen

1653004

USP

Theophyllin

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

1,3-Dimethyl-xanthin, 2,6-Dihydroxy-1,3-dimethyl-purin, 3,7-Dihydro-1,3-dimethyl-1H-purin-2,6-dion

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

200 MG
€ 386,00

€ 386,00

Check Cart for Availability
Bulk-Bestellung anfordern
Alle Fotos(1)

Größe auswählen

Ansicht ändern
200 MG
€ 386,00

About This Item

Empirische Formel (Hill-System):
C7H8N4O2
CAS-Nummer:
58-55-9
Molekulargewicht:
180.16
Beilstein:
13463
MDL-Nummer:
MFCD00079619
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329751262
NACRES:
NA.24

€ 386,00

Check Cart for Availability
Bulk-Bestellung anfordern

Qualität

pharmaceutical primary standard

API-Familie

theophylline

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

CN1C(=O)N(C)c2[nH]cnc2C1=O

InChI

1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)

InChIKey

ZFXYFBGIUFBOJW-UHFFFAOYSA-N

Angaben zum Gen

human ... ADORA1(134) , ADORA2A(135) , ADORA2B(136) , ADORA3(140) , PDE3A(5139) , PDE3B(5140) , PDE4A(5141) , PDE4B(5142) , PDE4C(5143) , PDE4D(5144)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Theophylline USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Aminophylline
  • Aminophylline Delayed-Release Tablets
  • Aminophylline Injection
  • Aminophylline Oral Solution
  • Aminophylline Rectal Solution
  • Aminophylline Tablets
  • Dimenhydrinate

Biochem./physiol. Wirkung

Phosphodiesterase Inhibitor; Diuretikum; Herzstimulant; Muskelrelaxans; Asthmamedikament.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1151

Theophyllin, Pharmaceutical Secondary Standard; Certified Reference Material

T0800000

Theophyllin, European Pharmacopoeia (EP) Reference Standard

1653117

Theophyllin-Schmelzpunktstandard, United States Pharmacopeia (USP) Reference Standard

1077708

8-Bromtheophyllin, United States Pharmacopeia (USP) Reference Standard

1653048

Theophyllin-verwandte Verbindung D, United States Pharmacopeia (USP) Reference Standard

1653037

Theophyllin-verwandte Verbindung C, United States Pharmacopeia (USP) Reference Standard

1653026

Theophyllin-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1653060

Theophyllin-verwandte Verbindung F, United States Pharmacopeia (USP) Reference Standard

BP327

Theophyllin, British Pharmacopoeia (BP) Reference Standard

PHR2588

Theophyllin-verwandte Verbindung F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2541

Theophyllin-verwandte Verbindung F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2551

N-Methyl-5-(methylamino)-1H-imidazol-4-carboxamid -hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material

1121038

8-Chlortheophyllin, United States Pharmacopeia (USP) Reference Standard

Piktogramme

Skull and crossbonesHealth hazard
GHS06,GHS08

Signalwort

Danger

H-Sätze

H301,H360D

Gefahreneinstufungen

Acute Tox. 3 Oral - Repr. 1B

Lagerklassenschlüssel

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Zulassungslistungen

Zulassungslistungen werden hauptsächlich für chemische Produkte erstellt. Für nicht-chemische Produkte können hier nur begrenzte Angaben gemacht werden. Kein Eintrag bedeutet, dass keine der Komponenten gelistet ist. Es liegt in der Verantwortung des Benutzers, die sichere und legale Verwendung des Produkts zu gewährleisten.

EU REACH Annex XVII (Restriction List)

CAS No.

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Bing Dai et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 60(3), 360-370 (2012-04-21)
Whether treatment with adenosine receptor antagonists such as theophylline can prevent contrast-induced acute kidney injury (AKI) remains controversial. We conducted a meta-analysis of randomized controlled trials using MEDLINE (1966 to July 2011), EMBASE (1980 to July 2011), Web of Science
Mazen Al-Alawi et al.
The American journal of medicine, 127(5), 370-378 (2014-01-02)
Global estimates on aging predict an increased burden of asthma in the older population. Consequently, its recognition, diagnosis, and management in clinical practice require optimization. This review aims to provide an update for clinicians, highlighting advances in the understanding of
F S F Ram et al.
Respiratory medicine, 99(2), 135-144 (2005-02-18)
To determine the efficacy of oral theophylline compared with placebo in people with stable chronic obstructive pulmonary disease (COPD). Systematic review of randomized-controlled trials comparing oral theophylline with placebo for a minimum of 7 days in people with stable COPD.
Sean M Bagshaw et al.
Archives of internal medicine, 165(10), 1087-1093 (2005-05-25)
Contrast-induced nephropathy (CIN) is an important cause of declines in kidney function and is related to greater morbidity, health care costs, and mortality. Adenosine has been proposed to contribute to the pathophysiological process of CIN. We performed a systematic review
David J Henderson-Smart et al.
The Cochrane database of systematic reviews, (1)(1), CD000273-CD000273 (2010-01-22)
Recurrent apnea is common in preterm infants, particularly at very early gestational ages. These episodes of loss of effective breathing can lead to hypoxemia and bradycardia, which may be severe enough to require resuscitation including use of positive pressure ventilation.
Alle zugehörigen Dokumente anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.